SAGA Diagnostics Alternatives & Competitors
12 companies similar to SAGA Diagnostics — Redefining the early detection of molecular residual disease (MRD).
Companies similar to SAGA Diagnostics
Leganes, Spain
CellMax Life
Liquid biopsy company focused on cancer screening with a proprietary platform for detectin...
Sunnyvale, United States
-logo.jpg "Foresight Diagnostics (a Natera company)"){kind=logo}
Foresight Diagnostics (a Natera company)
Precision medicine company dedicated to improving the lives of cancer patients through imp...
Boulder, United States
DiaCarta, Inc.
Redefining Precision Molecular Diagnostics through Cancer Gene Mutation Detection
Pleasanton, United States
Track all SAGA Diagnostics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Personalis, Inc.
Ultrasensitive ctDNA testing
Fremont, United States
Predicine
Advancing precision medicine through next-generation liquid biopsy oncology platform
Hayward, United States
Beijing, China
Geneseeq Technology Inc.
Cancer: a word, not a sentence!
Toronto, Canada
CIRCULOGENE
Patients deserve the BEST
Birmingham, United States
OncoDNA
Genomic and theranostic company specializing in precision medicine for the treatment of ca...
Belgium
Personal Genome Diagnostics
Leading the way in patient-specific cancer genome analysis with groundbreaking technologie...
ARNA Genomics
Pioneering early cancer diagnosis through advanced fluid biopsy technology
About SAGA Diagnostics
SAGA Diagnostics, founded in 2016, is making significant strides in the biotechnology industry by focusing on personalized cancer medicine. Their unique approach centers on molecular genetic analyses of circulating tumor DNA and tissue biopsies, aiming to revolutionize the early detection of molecular residual disease...
Molecular residual disease diagnostics, Pathlight MRD platform, Whole-genome sequencing, Customized digital PCR assays
Clinicians, Healthcare providers, Biopharma companies, Cancer patients (especially in early stages)
Personalized Cancer Medicine, Disease Monitoring, Circulating Tumor DNA, Liquid Biopsy, Molecular Genetic Analyses, Precision Oncology, Cancer Biomarker Analysis, Treatment Monitoring, Ultrasensitive Detection, Cancer Diagnostics, Companion Diagnostics, Digital PCR, Mutation Screening, Next-Generation Sequencing, Residual Disease Detection
B2B, B2C, B2B2C
Service Fee, Usage Based, Licensing
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches SAGA Diagnostics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at SAGA Diagnostics on 23 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 11 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
